Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14265
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKrajarng A.
dc.contributor.authorNilwarankoon S.
dc.contributor.authorSuksamrarn S.
dc.contributor.authorWatanapokasin R.
dc.date.accessioned2021-04-05T03:33:54Z-
dc.date.available2021-04-05T03:33:54Z-
dc.date.issued2012
dc.identifier.issn345288
dc.identifier.other2-s2.0-84863108518
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14265-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84863108518&doi=10.1016%2fj.rvsc.2012.01.015&partnerID=40&md5=5ce11b57663ec1f4cc4b389c5adeb1ce
dc.description.abstractOsteosarcoma is the most frequently diagnosed primary bone tumor in dog. Since chemotherapeutics are quite limited due to high cost and severe toxicity, therefore, the ultimate goal is to discover cost-effective therapeutics with less toxicity. We have studied the effect of α-mangostin, a xanthone derivative isolated from pericarp of mangosteen (Garcinia mangostana Linn.) in canine osteosarcoma, D-17 cells. The results showed that α-mangostin induced antiproliferation with IC50 at 15μg/ml. Hoechst 33342 nuclear staining and nucleosomal DNA-gel electrophoresis revealed that α-mangostin could induce nuclear condensation and fragmentation, typically seen in apoptosis. Cell cycle analysis demonstrated that α-mangostin induced sub-G1 peak. In addition, α-mangostin also induced membrane flipping of the phosphatidylserine and the loss of mitochondrial membrane potential in D-17 cells. In conclusion, α-mangostin, induced apoptotic cell death against canine osteosarcoma D-17 cells, could be a potential candidate for preventive and therapeutic application for bone cancer treatment in dogs. © 2012 Elsevier Ltd.
dc.subjectalpha mangostin
dc.subjectantineoplastic agent
dc.subjectDNA
dc.subjecthoe 33342
dc.subjectphosphatidylserine
dc.subjectunclassified drug
dc.subjectxanthone derivative
dc.subjectanimal cell
dc.subjectantiproliferative activity
dc.subjectapoptosis
dc.subjectarticle
dc.subjectcell cycle G1 phase
dc.subjectcell membrane
dc.subjectcell nucleus fragmentation
dc.subjectcell strain D 17
dc.subjectcellular parameters
dc.subjectconcentration response
dc.subjectcontrolled study
dc.subjectDNA fragmentation
dc.subjectdog
dc.subjectdrug cytotoxicity
dc.subjectdrug isolation
dc.subjectflow cytometry
dc.subjectGarcinia mangostana
dc.subjectgel electrophoresis
dc.subjectIC 50
dc.subjectmitochondrial membrane potential
dc.subjectnonhuman
dc.subjectnuclear condensation
dc.subjectnucleosome
dc.subjectosteosarcoma
dc.subjectosteosarcoma cell
dc.subjectpericarp
dc.subjectphospholipid metabolism
dc.subjectstaining
dc.subjectAnimals
dc.subjectAntineoplastic Agents, Phytogenic
dc.subjectCell Cycle
dc.subjectCell Line, Tumor
dc.subjectCell Proliferation
dc.subjectCell Survival
dc.subjectDogs
dc.subjectGarcinia mangostana
dc.subjectOsteosarcoma
dc.subjectXanthones
dc.subjectCanis familiaris
dc.subjectGarcinia mangostana
dc.titleAntiproliferative effect of α-mangostin on canine osteosarcoma cells
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationResearch in Veterinary Science. Vol 93, No.2 (2012), p.788-794
dc.identifier.doi10.1016/j.rvsc.2012.01.015
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.